mRNA vaccines like those manufactured by Pfizer and Moderna continue to be a recommendation of the province.
The Pfizer COVID-19 bivalent vaccine is available to kids between the ages of five and 11 as a first shot or as a booster. For kids between the ages of 12 and 17, they’ll have the Novavax Nuvaxovid vaccine available as a primary shot or booster.We deliver the local news you need in these turbulent times on weekdays at 3 p.m.By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc.
Novavax’s shot is a protein-based vaccine with no genetic material and has been available since April 2022. The province says mRNA vaccines, such as Moderna and Pfizer, are still the recommended vaccines for all residents. The province notes it is safe to take Moderna and Pfizer vaccines at the same time.Article content
“Being up-to-date on your vaccinations matters. Having a COVID-19 booster in the last six months reduces the risk of a COVID-19 death eight times compared to unvaccinated individuals, and more than four times compared to those without a recent booster dose,” the province said in a news release on Friday., which was an increase over the 802 deaths recorded in 2021.
The most recent provincial data, released on January 6 and covering the period from December 18 to 31, saw 302 confirmed cases of COVID-19 recorded. Nearly half of those cases, 47 per cent, were in people 65 and older. The province currently has 18 active COVID-19 outbreaks listed on its website, all of them in long-term care homes or personal care homes. Outbreaks connected to work, mass gatherings, school, etc. are no longer listed by the government.Article content
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer bivalent vax available for kids, Novavax for teens as of MondaymRNA vaccines like those manufactured by Pfizer and Moderna continue to be a recommendation of the province.
Read more »
Novavax’s stock rallies after the company names new CEOShares of Novavax Inc. were up about 9% in trading on Monday after the company said John Jacobs will take over as president and CEO on Jan. 23. Jacobs, the...
Read more »
Moderna’s COVID shot to generate $5.0 billion in sales in 2023Shares of Moderna Inc. were up about 1.0% in premarket trading on Monday after the company reiterated that it expects to have $5.0 billion in sales of its...
Read more »
WSJ: Moderna may charge up to $130 per dose of its COVID shotShares of Moderna Inc. were up 2.5% in trading on Monday afternoon after the Wall Street Journal reported that the company is considering pricing its...
Read more »
WSJ News Exclusive | Moderna Considers Price of $110-$130 for Covid-19 VaccineModerna is considering a price of $110-$130 for its Covid-19 vaccine after distribution shifts from government contracting to the commercial market
Read more »
Moderna’s Bancel Prepares for Transition Year as COVID Vaccine Sales Wane(Bloomberg) — Moderna Inc. is looking for potential approval of two new vaccines this year to help compensate for waning sales of its Covid-19 shot, according to Chief Executive Officer Steph…
Read more »